Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women.

Elffers TW, de Mutsert R, Lamb HJ, de Roos A, Willems van Dijk K, Rosendaal FR, Jukema JW, Trompet S.

PLoS One. 2017 Sep 28;12(9):e0185403. doi: 10.1371/journal.pone.0185403. eCollection 2017.

2.

The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy.

Moon S, Oh CM, Choi MK, Park YK, Chun S, Choi M, Yu JM, Yoo HJ.

PLoS One. 2017 Sep 26;12(9):e0185127. doi: 10.1371/journal.pone.0185127. eCollection 2017.

3.

Obesity and kidney disease: hidden consequences of the epidemic.

Kovesdy CP, Furth SL, Zoccali C; World Kidney Day Steering Committee.

Future Sci OA. 2017 Feb 6;3(3):FSO159. doi: 10.4155/fsoa-2016-0081. eCollection 2017 Aug. Review.

4.

Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort.

Owei I, Umekwe N, Provo C, Wan J, Dagogo-Jack S.

BMJ Open Diabetes Res Care. 2017 Jul 19;5(1):e000415. doi: 10.1136/bmjdrc-2017-000415. eCollection 2017.

5.

Obesity and Kidney Disease: Hidden Consequences of the Epidemic.

Kovesdy CP, Furth SL, Zoccali C; World Kidney Day Steering Committee.

Kidney Dis (Basel). 2017 Jul;3(1):33-41. doi: 10.1159/000452965. Epub 2017 Feb 3.

6.

Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study.

Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ.

F1000Res. 2017 May 3;6:614. doi: 10.12688/f1000research.11359.1. eCollection 2017.

7.

Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype.

Kang YM, Jung CH, Cho YK, Jang JE, Hwang JY, Kim EH, Lee WJ, Park JY, Kim HK.

PLoS One. 2017 Jun 23;12(6):e0179635. doi: 10.1371/journal.pone.0179635. eCollection 2017.

8.

Obesity and kidney disease: hidden consequences of the epidemic.

Kovesdy CP, L Furth S, Zoccali C; World Kidney Day Steering Committee.

Clin Kidney J. 2017 Feb;10(1):1-8. doi: 10.1093/ckj/sfw139. Epub 2017 Jan 25.

9.

Metabolically healthy obesity: a friend or foe?

Jung CH, Lee WJ, Song KH.

Korean J Intern Med. 2017 Jul;32(4):611-621. doi: 10.3904/kjim.2016.259. Epub 2017 Jun 5. Review.

10.

Adipose tissue dysfunction as a central mechanism leading to dysmetabolic obesity triggered by chronic exposure to p,p'-DDE.

Pestana D, Teixeira D, Meireles M, Marques C, Norberto S, Sá C, Fernandes VC, Correia-Sá L, Faria A, Guardão L, Guimarães JT, Cooper WN, Sandovici I, Domingues VF, Delerue-Matos C, Monteiro R, Constância M, Calhau C.

Sci Rep. 2017 Jun 1;7(1):2738. doi: 10.1038/s41598-017-02885-9.

11.

Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals.

Frederiksen SD, Karlskov-Mortensen P, Pant SD, Guerin M, Lesnik P, Jørgensen CB, Cirera S, Bruun CS, Mark T, Fredholm M.

PLoS One. 2017 Jun 1;12(6):e0178828. doi: 10.1371/journal.pone.0178828. eCollection 2017.

12.

Global transcriptome profiling identifies KLF15 and SLC25A10 as modifiers of adipocytes insulin sensitivity in obese women.

Kulyté A, Ehrlund A, Arner P, Dahlman I.

PLoS One. 2017 Jun 1;12(6):e0178485. doi: 10.1371/journal.pone.0178485. eCollection 2017.

13.

APMAP interacts with lysyl oxidase-like proteins, and disruption of Apmap leads to beneficial visceral adipose tissue expansion.

Pessentheiner AR, Huber K, Pelzmann HJ, Prokesch A, Radner FPW, Wolinski H, Lindroos-Christensen J, Hoefler G, Rülicke T, Birner-Gruenberger R, Bilban M, Bogner-Strauss JG.

FASEB J. 2017 Sep;31(9):4088-4103. doi: 10.1096/fj.201601337R. Epub 2017 May 30.

14.

Obesity and Kidney Disease: Hidden Consequences of the Epidemic.

Kovesdy CP, Furth SL, Zoccali C; World Kidney Day Steering Committee.

Can J Kidney Health Dis. 2017 Mar 8;4:2054358117698669. doi: 10.1177/2054358117698669. eCollection 2017.

15.

Genome-wide DNA methylation analysis reveals loci that distinguish different types of adipose tissue in obese individuals.

Macartney-Coxson D, Benton MC, Blick R, Stubbs RS, Hagan RD, Langston MA.

Clin Epigenetics. 2017 May 3;9:48. doi: 10.1186/s13148-017-0344-4. eCollection 2017.

16.

Hematopoietic-to-mesenchymal transition of adipose tissue macrophages is regulated by integrin β1 and fabricated fibrin matrices.

Gavin KM, Majka SM, Kohrt WM, Miller HL, Sullivan TM, Klemm DJ.

Adipocyte. 2017 Jul 3;6(3):234-249. doi: 10.1080/21623945.2017.1314403. Epub 2017 Apr 3.

PMID:
28441086
17.

Very-long-chain ω-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial.

Hames KC, Morgan-Bathke M, Harteneck DA, Zhou L, Port JD, Lanza IR, Jensen MD.

Am J Clin Nutr. 2017 Jun;105(6):1552-1558. doi: 10.3945/ajcn.116.148114. Epub 2017 Apr 19.

PMID:
28424185
18.

Obesity and kidney disease: hidden consequences of the epidemic.

Kovesdy CP, Furth SL, Zoccali C.

Braz J Med Biol Res. 2017 Apr 13;50(5):e6075. doi: 10.1590/1414-431X20166075. Review.

19.

"Obesity-Associated" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk.

Denis GV, Palmer JR.

Cancer Prev Res (Phila). 2017 May;10(5):267-269. doi: 10.1158/1940-6207.CAPR-17-0083. Epub 2017 Apr 13.

PMID:
28408379
20.

Association between Indices of Body Composition and Abnormal Metabolic Phenotype in Normal-Weight Chinese Adults.

Xia L, Dong F, Gong H, Xu G, Wang K, Liu F, Pan L, Zhang L, Yan Y, Gaisano H, He Y, Shan G.

Int J Environ Res Public Health. 2017 Apr 7;14(4). pii: E391. doi: 10.3390/ijerph14040391.

Supplemental Content

Support Center